Different Modalities for the Evaluation of Patients With Peri-menopausal Bleeding

Three Dimensional Ultrasonography Versus Hysteroscopy for the Evaluation of Patients With Perimenopausal Bleeding

Status

Recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07309692

Enrollment

106

Registered

2025-12-30

Start date

2025-12-01

Completion date

2026-08-31

Last updated

2025-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perimenopausal Bleeding

Keywords

ultrasonography, hysteroscopy

Brief summary

The study aims to compare between 3D ultrasonography and hysteroscopy for the evaluation of cases with Peri-menopausal bleeding

Interventions

DIAGNOSTIC_TESTthree dimensional ultrasonography

all recruited patients will be subjected to three dimensional ultrasonography to diagnose the cause of perimenopausal bleeding

DIAGNOSTIC_TESTHysteroscopy

diagnostic hysteroscopy will be performed to diagnose the cause of perimenopausal bleeding

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

40 Years to 55 Years

Healthy volunteers

Inclusion criteria

Any pattern of abnormal uterine bleeding as menorrhagia or metrorrhagia for more than 3 months at age between 40 and 55 years , and no ovarian lesion or local cause of bleeding as vaginal or cervical ulcer

Exclusion criteria

* • Women with postmenopausal bleeding. * Systemic causes of perimenopausal bleeding DM Hypertension or chronic liver disease. * Women on hormonal therapy or using any contraception as IUD. * Women have contraindication for hysteroscopy as cervical stenosis or pregnancy.

Design outcomes

Primary

Measure	Time frame
The sensitivity and specificity of the 3D ultrasonography for the diagnosis of the causes of peri-menopausal bleeding as compared to hysteroscopy	9 months

Countries

Egypt

Contacts

Primary Contactahmed abdelrahem fattouh, resident of Obstetrics and Gyn

ahmedalatoon04@gmail.com00201146329946

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026